LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Hypoxia-induced therapy resistance: Available hypoxia-targeting strategies and current advances in head and neck cancer

Photo from wikipedia

Highlights • Hypoxia has long been recognised as a major cause of treatment failure in solid tumour and is a crucial feature of aggressive tumours.• Head and neck cancers have… Click to show full abstract

Highlights • Hypoxia has long been recognised as a major cause of treatment failure in solid tumour and is a crucial feature of aggressive tumours.• Head and neck cancers have limited treatment options and remain dependent on radiotherapy, hypoxic adaption is particularly restrictive to RT success.• To reverse, correct or diminish hypoxia has important benefits in treatment sensitization of head and neck cancers to RT, chemo- and immunotherapy.• We provide an overview of all main strategies to target tumor hypoxia: HIF-inhibitors, hypoxia-activated prodrugs, and anti-angiogenic agents.• We underline emerging strategies towards efficient delivery of drugs to combat restrictive microenvironment of hypoxic tumour tissue.

Keywords: resistance available; hypoxia; therapy resistance; induced therapy; hypoxia induced; head neck

Journal Title: Translational Oncology
Year Published: 2021

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.